Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease
- PMID: 21674591
- PMCID: PMC3170496
- DOI: 10.1002/ana.22454
Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease
Abstract
Objective: Heightened awareness of Creutzfeldt-Jakob disease (CJD) among physicians and the lay public has led to its frequent consideration in the differential diagnosis of patients with rapidly progressive dementia (RPD). Our goal was to determine which treatable disorders are most commonly mistaken for CJD.
Methods: We performed a retrospective clinical and neuropathological review of prion-negative brain autopsy cases referred to the US National Prion Disease Pathology Surveillance Center at Case Western Reserve University from January 2006 through December 2009.
Results: Of 1,106 brain autopsies, 352 (32%) were negative for prion disease, 304 of which had adequate tissue for histopathological analysis. Alzheimer disease (n = 154) and vascular dementia (n = 36) were the 2 most frequent diagnoses. Seventy-one patients had potentially treatable diseases. Clinical findings included dementia (42 cases), pyramidal (n = 20), cerebellar (n = 14), or extrapyramidal (n = 12) signs, myoclonus (n = 12), visual disturbance (n = 9), and akinetic mutism (n = 5); a typical electroencephalogram occurred only once. Neuropathological diagnoses included immune-mediated disorders (n = 26), neoplasia (n = 25, most often lymphoma), infections (n = 14), and metabolic disorders (n = 6).
Interpretation: In patients with RPD, treatable disorders should be considered and excluded before diagnosing CJD. Misdiagnosed patients often did not fulfill World Health Organization criteria. RPD with positive 14-3-3 cerebrospinal fluid protein should not be regarded as sufficient for the diagnosis of CJD. Adherence to revised criteria for CJD, which include distinctive magnetic resonance imaging features of prion disease, is likely to improve diagnostic accuracy.
Copyright © 2011 American Neurological Association.
Figures


Comment in
-
Thorough work-up and new diagnostic criteria needed for CJD.Nat Rev Neurol. 2011 Sep 5;7(9):479-80. doi: 10.1038/nrneurol.2011.118. Nat Rev Neurol. 2011. PMID: 21892213 Free PMC article.
References
-
- Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14–3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003;60:813–816. - PubMed
-
- Satoh J, Kurohara K, Yukitake M, Kuroda Y. The 14–3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 1999;41:216–225. - PubMed
-
- Poser S, Mollenhauer B, Kraubeta A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain. 1999;122 ( Pt 12):2345–2351. - PubMed